VANGUARD GROUP INC 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 3:18 pm Sale | 2025-09-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | VANGUARD GROUP INC | 408,222 4.700% | -102,077 (-20.00%) | Filing |